Mary Panaccio

458 total citations
28 papers, 342 citations indexed

About

Mary Panaccio is a scholar working on Neurology, Rheumatology and Surgery. According to data from OpenAlex, Mary Panaccio has authored 28 papers receiving a total of 342 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Neurology, 9 papers in Rheumatology and 6 papers in Surgery. Recurrent topics in Mary Panaccio's work include Peripheral Neuropathies and Disorders (9 papers), Rheumatoid Arthritis Research and Therapies (7 papers) and Systemic Lupus Erythematosus Research (6 papers). Mary Panaccio is often cited by papers focused on Peripheral Neuropathies and Disorders (9 papers), Rheumatoid Arthritis Research and Therapies (7 papers) and Systemic Lupus Erythematosus Research (6 papers). Mary Panaccio collaborates with scholars based in United States, Ireland and United Kingdom. Mary Panaccio's co-authors include Robert J. Sanchez, Gerald V. Naccarelli, Nora Tu, Usha G. Mallya, Andrew Koren, Peter J. Neumann, Joseph Menzin, Mark I. Friedman, Jennifer Sung and George J. Wan and has published in prestigious journals such as The American Journal of Cardiology, Annals of the Rheumatic Diseases and The American Journal of Gastroenterology.

In The Last Decade

Mary Panaccio

24 papers receiving 330 citations

Peers

Mary Panaccio
Debra Wertz United States
Alice Heaney United Kingdom
M Barbeau Canada
Swapna Karkare United States
David J. Harrison United States
Şule Arslan Türkiye
H.J. Gross United States
Robert Wetz United States
Debra Wertz United States
Mary Panaccio
Citations per year, relative to Mary Panaccio Mary Panaccio (= 1×) peers Debra Wertz

Countries citing papers authored by Mary Panaccio

Since Specialization
Citations

This map shows the geographic impact of Mary Panaccio's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mary Panaccio with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mary Panaccio more than expected).

Fields of papers citing papers by Mary Panaccio

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mary Panaccio. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mary Panaccio. The network helps show where Mary Panaccio may publish in the future.

Co-authorship network of co-authors of Mary Panaccio

This figure shows the co-authorship network connecting the top 25 collaborators of Mary Panaccio. A scholar is included among the top collaborators of Mary Panaccio based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mary Panaccio. Mary Panaccio is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Velez, Fulton, Ravi R. Rajani, Daniel C. Malone, et al.. (2025). Budget impact model of acellular tissue engineered vessel for the repair of extremity arterial trauma when autologous vein is not feasible. Journal of Medical Economics. 28(1). 323–334.
2.
Chopra, Ishveen, et al.. (2024). Acthar Gel in African Americans versus Non-African Americans with Symptomatic Sarcoidosis: Physician Assessment of Patient Medical Records. Therapeutics and Clinical Risk Management. Volume 20. 83–94. 1 indexed citations
3.
Wong, Robert J., et al.. (2024). S1957 Trends in the Early Adoption of Terlipressin Among Hospitalized Adults With Hepatorenal Syndrome in the US: A Real-World Analysis. The American Journal of Gastroenterology. 119(10S). S1400–S1401. 1 indexed citations
4.
Chopra, Ishveen, et al.. (2023). Cost-Effectiveness of Acthar Gel versus Standard of Care for the Treatment of Advanced Symptomatic Sarcoidosis. ClinicoEconomics and Outcomes Research. Volume 15. 739–752. 1 indexed citations
5.
Fleischmann, Roy, et al.. (2022). Post Hoc Analysis of Predictors of Clinical Response to Repository Corticotropin Injection in Persistently Active Rheumatoid Arthritis. Rheumatology and Therapy. 9(2). 649–661. 1 indexed citations
6.
Girman, Cynthia J., et al.. (2022). Pain and Fatigue Improvements in Patients Treated with Repository Corticotropin Injection Across Five Indications: A Narrative Review. Advances in Therapy. 39(7). 3072–3087. 2 indexed citations
7.
8.
Wan, George J., et al.. (2022). Real-world treatment patterns for repository corticotropin injection in patients with rheumatoid arthritis. Drugs in Context. 11. 1–12. 2 indexed citations
11.
Panaccio, Mary, et al.. (2021). Real-World Treatment Patterns and Outcomes from an Electronic Medical Records Database for Patients with Rheumatoid Arthritis Treated with Repository Corticotropin Injection. Open Access Rheumatology Research and Reviews. Volume 13. 315–323. 4 indexed citations
13.
Rice, J. Bradford, et al.. (2021). Consequences of insurance denials among U.S. patients prescribed repository corticotropin injection (Acthar Gel) for nephrotic syndrome. Current Medical Research and Opinion. 37(3). 431–441. 2 indexed citations
14.
Hunter, Samuel F., et al.. (2021). Cost-Effectiveness of Repository Corticotropin Injection for the Treatment of Acute Exacerbations in Multiple Sclerosis. ClinicoEconomics and Outcomes Research. Volume 13. 883–892. 2 indexed citations
15.
Sarri, Grammati, Elisabetta Patorno, Hongbo Yuan, et al.. (2020). Framework for the synthesis of non-randomised studies and randomised controlled trials: a guidance on conducting a systematic review and meta-analysis for healthcare decision making. BMJ evidence-based medicine. 27(2). 109–119. 68 indexed citations
16.
Graham, Jove, Robert J. Sanchez, Joseph J. Saseen, et al.. (2016). Clinical and economic consequences of statin intolerance in the United States: Results from an integrated health system. Journal of clinical lipidology. 11(1). 70–79.e1. 38 indexed citations
17.
Sung, Jennifer, Robert J. Sanchez, Usha G. Mallya, et al.. (2016). Patterns of Statin Use in a Real-World Population of Patients at High Cardiovascular Risk. Journal of Managed Care & Specialty Pharmacy. 22(6). 685–698. 76 indexed citations
18.
Panaccio, Mary, Charles Wentworth, Stephan Lanes, et al.. (2015). A common data model to assess cardiovascular hospitalization and mortality in atrial fibrillation patients using administrative claims and medical records. Clinical Epidemiology. 7. 77–77. 11 indexed citations
19.
Naccarelli, Gerald V., et al.. (2012). CHADS2 and CHA2DS2-VASc Risk Factors to Predict First Cardiovascular Hospitalization Among Atrial Fibrillation/Atrial Flutter Patients. The American Journal of Cardiology. 109(10). 1526–1533. 58 indexed citations
20.
Heyer, Nicholas, Thaís C. Morata, Lynne E. Pinkerton, et al.. (2010). Use of historical data and a novel metric in the evaluation of the effectiveness of hearing conservation program components. Occupational and Environmental Medicine. 68(7). 510–517. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026